Name:
ZepzelcaTM (lurbinectedin: development of innovative drugs through marine organisms)

Developed by:
PHARMAMAR, SPAINSpain

Funding sources:
National

General idea:
Zepzelca (lurbinectedin), also known as PM1183, is an analog of the marine compound ET-736 isolated from the sea squirt Ecteinacidia turbinata in which a hydrogen atom has been replaced by a methoxy group.

TRL:
9. Actual system proven in operational environment

IPR involved:
Yes

Sources:
https://pharmamar.com/science-and-innovation/oncology-pipeline/?lang=en